Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

AFJKAimei Health Technology Co., Ltd.

Nasdaq · CIK 0001979005
Filer category<br>Emerging growth company
Entity typeoperating
SIC6770 Blank Checks
FY end1231
XBRL facts83

Identity from submissions API

NameAimei Health Technology Co., Ltd.
CIK0001979005
TickersAFJK, AFJKR, AFJKU
ExchangesNasdaq, Nasdaq, Nasdaq
Entity typeoperating
Category<br>Emerging growth company
SIC6770 Blank Checks
EIN000000000
LEI—
Fiscal year end1231
State of incorporation—
Phone34 678 035200
Website—
Investor website—
Owner org05 Real Estate & Construction
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
10 EAST 53RD STREET
SUITE 3001
NEW YORK
NY
10022
NY
Mailing address
10 EAST 53RD STREET
SUITE 3001
NEW YORK
NY
10022
NY

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

128 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-19 8-K 8-K 1.01,3.03,5.03,5.07,8.01,9.01 0001493152-26-053250 001-41880 261574816 34 14915954 1 1
2026-11-17 8-K 8-K 7.01 0001493152-26-052818 001-41880 261565983 34 279677 1 1
2026-11-16 10-Q 10-Q 0001493152-26-052354 001-41880 261560589 34 3715815 1 1
2026-11-05 8-K 8-K 2.03,9.01 0001493152-26-050234 001-41880 261527198 34 325372 1 1
2026-11-03 8-K/A 8-K/A 2.03,9.01 0001493152-26-049665 001-41880 261513987 34 323798 1 1
2026-10-19 DEF 14A DEF 14A 0001493152-26-047583 001-41880 261469035 34 2000586
2026-10-09 PRE 14A PRE 14A 0001493152-26-046430 001-41880 261451161 34 2000560
2026-10-05 8-K 8-K 2.03,9.01 0001493152-26-045745 001-41880 261440361 34 322845 1 1
2026-09-03 8-K 8-K 2.03,9.01 0001493152-26-041316 001-41880 261356741 34 321330 1 1
2026-08-25 8-K 8-K 3.01,9.01 0001493152-26-040044 001-41880 261315735 34 268916 1 1
2026-08-13 10-Q 10-Q 0001493152-26-037588 001-41880 261270126 34 3219787 1 1
2026-08-10 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001604488-26-000081 005-94248 261257420 34 16950
2026-08-06 8-K 8-K 2.03,9.01 0001493152-26-036336 001-41880 261248905 34 322418 1 1
2026-08-05 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001628280-26-053520 005-94248 261244777 34 112762
2026-07-08 8-K 8-K 1.02,7.01,9.01 0001493152-26-032541 001-41880 261163083 34 279007 1 1
2026-07-06 8-K 8-K 2.03,9.01 0001493152-26-032151 001-41880 261155874 34 319773 1 1
2026-07-01 3 3 0001493152-26-031457 3270
2026-06-29 8-K 8-K 5.02,9.01 0001493152-26-031065 001-41880 261135721 34 267353 1 1
2026-06-16 10-Q 10-Q 0001493152-26-028880 001-41880 261094625 34 3079015 1 1
2026-06-04 8-K 8-K 2.03,9.01 0001493152-26-027265 001-41880 261064905 34 321577 1 1
2026-05-20 8-K 8-K 3.01,9.01 0001493152-26-024600 001-41880 261003943 34 284570 1 1
2026-05-06 8-K 8-K 2.03,9.01 0001493152-26-021486 001-41880 26948270 34 322614 1 1
2026-05-04 10-K 10-K 0001493152-26-021108 001-41880 26937500 34 3820709 1 1
2026-04-21 8-K 8-K 3.01,9.01 0001493152-26-018216 001-41880 26876850 34 282975 1 1
2026-04-07 8-K 8-K 2.03,9.01 0001493152-26-015512 001-41880 26844726 34 326389 1 1
2026-04-01 NT 10-K NT 10-K 0001493152-26-014635 001-41880 26828105 34 37188
2026-03-04 8-K 8-K 2.03,9.01 0001493152-26-008853 001-41880 26721178 34 306726 1 1
2026-02-13 8-K 8-K 2.03,9.01 0001493152-26-006694 001-41880 26632628 34 323899 1 1
2026-02-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-26-013875 005-94248 26623436 34 36041
2026-01-07 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001072613-26-000035 005-94248 26515648 34 7762
2026-01-06 8-K 8-K 2.03,9.01 0001493152-26-000589 001-41880 26511430 34 322146 1 1
2025-12-08 8-K 8-K 2.03,9.01 0001493152-25-026631 001-41880 251556129 34 322179 1 1
2025-12-02 8-K 8-K 1.01,3.03,5.03,5.07,8.01,9.01 0001493152-25-025731 001-41880 251543165 34 359635 1 1
2025-11-18 10-Q 10-Q 0001493152-25-024062 001-41880 251494633 34 3446095 1 1
2025-11-14 NT 10-Q NT 10-Q 0001493152-25-023415 001-41880 251485777 34 37302
2025-11-12 8-K 8-K 5.07,8.01,9.01 0001493152-25-021585 001-41880 251467805 34 296207 1 1
2025-11-10 DEF 14A DEF 14A 0001493152-25-021405 001-41880 251464999 34 2113291
2025-11-07 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001140361-25-041137 005-94248 251462352 34 11300
2025-11-04 8-K 8-K 2.03,9.01 0001493152-25-020720 001-41880 251448977 34 325594 1 1
2025-10-29 PRE 14A PRE 14A 0001493152-25-020097 001-41880 251430784 34 1437309
2025-10-10 DEF 14A DEF 14A 0001493152-25-017757 001-41880 251388139 34 10241649
2025-10-09 8-K 8-K 2.03,9.01 0001493152-25-017497 001-41880 251383492 34 322968 1 1
2025-09-05 8-K 8-K 2.03,9.01 0001493152-25-012726 001-41880 251296769 34 322051 1 1
2025-09-04 UPLOAD filename1.pdf 0000000000-25-009574 001-41880 39701
2025-08-26 10-K/A 10-K/A 0001493152-25-012343 001-41880 251257601 34 4540996 1 1
2025-08-13 10-Q 10-Q 0001493152-25-011904 001-41880 251211577 34 3361679 1 1
2025-08-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-077124 005-94248 251208855 34 33369
2025-08-08 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-105958 005-94248 251199118 34 144419
2025-08-06 8-K 8-K 2.03,9.01 0001641172-25-022421 001-41880 251189492 34 320220 1 1
2025-07-30 UPLOAD filename1.pdf 0000000000-25-007988 001-41880 42943
2025-07-07 8-K 8-K 2.03,9.01 0001641172-25-017980 001-41880 251108003 34 321847 1 1
2025-06-11 8-K 8-K 1.01,9.01 0001641172-25-014697 001-41880 251039955 34 326526 1 1
2025-06-06 8-K 8-K 2.03,9.01 0001641172-25-013936 001-41880 251028917 34 317818 1 1
2025-05-14 10-Q 10-Q 0001641172-25-010315 001-41880 25946611 34 3029881 1 1
2025-05-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-069766 005-94248 25937051 34 114530
2025-05-06 8-K 8-K 2.03,9.01 0001641172-25-008830 001-41880 25917084 34 330424 1 1
2025-04-08 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000899140-25-000536 005-94248 25823108 34 16009
2025-04-07 8-K form8-k.htm 2.03,9.01 0001641172-25-002979 001-41880 25818085 34 327185 1 1
2025-03-28 10-K form10-k.htm 0001641172-25-001169 001-41880 25785731 34 4558153 1 1
2025-03-07 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001072613-25-000212 005-94248 25719918 34 7722
2025-03-07 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001604488-25-000093 005-94248 25718563 34 16837
2025-03-06 8-K form8-k.htm 2.03,9.01 0001493152-25-009288 001-41880 25713506 34 315230 1 1
2025-02-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001076809-25-000026 005-94248 25629355 34 9032
2025-02-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001076809-25-000013 005-94248 25625821 34 8862
2025-02-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001085146-25-001217 005-94248 25618750 34 8586
2025-02-13 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-019352 005-94248 25617337 34 728305
2025-02-11 4 PRIMARY DOCUMENT 0000812291-25-000005 5075
2025-02-11 3 PRIMARY DOCUMENT 0000812291-25-000004 4133
2025-02-07 8-K form8-k.htm 1.01,2.03,3.03,5.03,5.07,8.01,9.01 0001493152-25-005465 001-41880 25602980 34 417276 1 1
2025-02-04 DEFA14A formdefa14a.htm 0001493152-25-004799 001-41880 25586075 34 17611
2025-02-04 8-K form8-k.htm 5.07 0001493152-25-004797 001-41880 25586064 34 268751 1 1
2025-01-31 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001140361-25-002636 005-94248 25576160 34 12551
2025-01-30 DEFA14A formdefa14a.htm 0001493152-25-004227 001-41880 25571965 34 1294908
2025-01-21 DEF 14A formdef14a.htm 0001493152-25-002879 001-41880 25540727 34 4957635
2025-01-14 8-K form8-k.htm 2.03,9.01 0001493152-25-002030 001-41880 25527789 34 335740 1 1
2025-01-10 PRE 14A formpre14a.htm 0001493152-25-001597 001-41880 25521540 34 1498432
2024-12-31 8-K form8-k.htm 5.07,9.01 0001493152-24-052702 001-41880 241593116 34 289016 1 1
2024-12-13 8-K form8-k.htm 2.03,9.01 0001493152-24-049990 001-41880 241548354 34 3028992 1 1
2024-12-03 DEF 14A formdef14a.htm 0001493152-24-048354 001-41880 241520833 34 1410905
2024-11-21 PRE 14A formpre14a.htm 0001493152-24-047114 001-41880 241483740 34 1420063
2024-11-14 SC 13G/A afjku20240930.htm 0001076809-24-000130 005-94248 241464809 34 61312
2024-11-14 SC 13G AFJK 13G 0001604488-24-000225 005-94248 241460121 34 80794
2024-11-13 10-Q form10-q.htm 0001493152-24-045119 001-41880 241454054 34 3199672 1 1
2024-11-13 SC 13G/A COWEN AND COMPANY, LLC 0001085146-24-005619 005-94248 241453821 34 27684
2024-11-13 SC 13G/A SC 13G/A 0001193125-24-256852 005-94248 241452109 34 98152
2024-10-16 SC 13G SC 13G 0001140361-24-043487 005-94248 241373436 34 165350
2024-08-09 10-Q form10-q.htm 0001493152-24-030872 001-41880 241190448 34 3123724 1 1
2024-06-20 8-K form8-k.htm 1.01,7.01,9.01 0001493152-24-024409 001-41880 241054042 34 2256082 1 1
2024-05-13 10-Q form10-q.htm 0001493152-24-018883 001-41880 24939165 34 2960643 1 1
2024-04-19 8-K form8-k.htm 5.02 0001493152-24-015354 001-41880 24858452 34 263708 1 1
2024-04-09 SC 13G KARPUS INVESTMENT MGT / AIMEI HEALTH TECHNOLOGY - SCHEDULE 13G 0001072613-24-000365 005-94248 24832676 34 77323
2024-03-25 10-K form10-k.htm 0001493152-24-011146 001-41880 24779729 34 3265286 1 1
2024-03-08 SC 13G SCHEDULE 13G 0001174947-24-000324 005-94248 24734231 34 73333
2024-02-14 SC 13G afjku20231231.htm 0001076809-24-000050 005-94248 24634382 34 66334
2024-02-14 SC 13G/A SC 13G/A 0001140361-24-007679 005-94248 24632065 34 168025
2024-02-08 SC 13G SC 13G 0001140361-24-006395 005-94248 24609045 34 156661
2024-02-02 SC 13G COWEN AND COMPANY, LLC 0001085146-24-000683 005-94248 24590519 34 27570
2024-01-31 SC 13G SC 13G 0001193125-24-020131 005-94248 24580538 34 104754
2024-01-18 8-K form8-k.htm 8.01,9.01 0001493152-24-002911 001-41880 24542198 34 275825 1 1
2023-12-15 SC 13D formsc13d.htm 0001493152-23-044941 005-94248 231488607 34 108388
2023-12-12 8-K form8-k.htm 8.01,9.01 0001493152-23-044552 001-41880 231481256 34 400835 1 1
2023-12-08 SC 13G SC 13G 0001193125-23-290989 005-94248 231473849 34 102357
2023-12-07 8-K form8-k.htm 1.01,3.02,5.03,8.01,9.01 0001493152-23-043918 001-41880 231470844 34 3042068 1 1
2023-12-05 4 xslF345X05/ownership.xml 0001493152-23-043708 7985
2023-12-05 424B4 form424b4.htm 0001493152-23-043705 333-272230 231467106 33 1922513
2023-12-01 CERT 8A_cert_AFJK.pdf 0001354457-23-000902 001-41880 231457859 34 180179
2023-11-30 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2023-11-30 16:00:00 9999999995-23-003500 333-272230 231457417 33 1663
2023-11-30 3 xslF345X02/ownership.xml 0001493152-23-043287 3410
2023-11-30 3 xslF345X02/ownership.xml 0001493152-23-043285 3397
2023-11-30 3 xslF345X02/ownership.xml 0001493152-23-043283 3422
2023-11-30 3 xslF345X02/ownership.xml 0001493152-23-043281 3467
2023-11-30 3 xslF345X02/ownership.xml 0001493152-23-043279 3443
2023-11-30 3 xslF345X02/ownership.xml 0001493152-23-043277 4485
2023-11-30 8-A12B form8a-12b.htm 0001493152-23-043200 001-41880 231455399 34 23232
2023-11-28 CORRESP filename1.htm 0001493152-23-042929 12678
2023-11-28 CORRESP filename1.htm 0001493152-23-042927 14586
2023-10-27 S-1/A forms-1a.htm 0001493152-23-038504 333-272230 231355280 33 4253112
2023-10-06 S-1/A forms-1a.htm 0001493152-23-036467 333-272230 231313375 33 4176252
2023-08-31 CORRESP filename1.htm 0001493152-23-031357 41832
2023-08-31 S-1/A forms-1a.htm 0001493152-23-031047 333-272230 231228854 33 2386146
2023-08-23 UPLOAD filename1.pdf 0000000000-23-009278 47197
2023-08-17 CORRESP filename1.htm 0001493152-23-029295 49396
2023-08-17 S-1/A forms-1a.htm 0001493152-23-029293 333-272230 231181659 33 3219316
2023-08-07 UPLOAD filename1.pdf 0000000000-23-008525 48871
2023-07-24 CORRESP filename1.htm 0001493152-23-025303 80542
2023-07-24 S-1/A forms-1a.htm 0001493152-23-025299 333-272230 231103614 33 17091141
2023-06-21 UPLOAD filename1.pdf 0000000000-23-006631 63718
2023-05-26 S-1 forms-1.htm 0001493152-23-019212 333-272230 23967087 33 1826900

Latest XBRL company facts

One latest value per concept from companyfacts (83 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 3.17M 2026-11-13 2026 Q3 10-Q 2026-11-16 0001493152-26-052354
dei EntityListingParValuePerShare Entity Listing, Par Value Per Share USD/shares 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-05-04 0001493152-26-021108
dei EntityPublicFloat Entity Public Float USD 44.55M 2025-06-30 2025 FY 10-K 2026-05-04 0001493152-26-021108
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 317,293 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052354
us-gaap AccruedLiabilitiesCurrentAndNoncurrent Accrued Liabilities USD 90,000 2024-09-30 2024 Q3 10-Q 2024-11-13 0001493152-24-045119
us-gaap Assets Assets USD 12.79M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052354
us-gaap AssetsCurrent Assets, Current USD 51,396 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052354
us-gaap AssetsHeldInTrust Assets Held-in-trust USD 12.74M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052354
us-gaap AssetsHeldInTrustNoncurrent Assets Held-in-trust, Noncurrent USD 12.74M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052354
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment USD 5.00M 2026-06-30 2026 Q2 10-Q 2026-08-13 0001493152-26-037588
us-gaap Cash Cash USD 3,373 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052354
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 3,373 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052354
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 444 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052354
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052354
us-gaap CashFDICInsuredAmount Cash, FDIC Insured Amount USD 250,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052354
us-gaap CashUninsuredAmount Cash, Uninsured Amount USD 0 2025-09-30 2025 Q3 10-Q 2025-11-18 0001493152-25-024062
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052354
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 500.00M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052354
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 2.13M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052354
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 2.13M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052354
us-gaap CommonStockShareSubscribedButUnissuedSubscriptionsReceivable Common Stock, Share Subscribed but Unissued, Subscriptions Receivable USD 25,000 2023-05-08 2024 Q3 10-Q 2024-11-13 0001493152-24-045119
us-gaap CommonStockValue Common Stock, Value, Issued USD 213 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052354
us-gaap DebtInstrumentConvertibleConversionPrice1 Debt Instrument, Convertible, Conversion Price USD/shares 10 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052354
us-gaap DeferredCompensationLiabilityClassifiedNoncurrent Deferred Compensation Liability, Classified, Noncurrent USD 690,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052354
us-gaap DepositAssets Deposit Assets USD 34,331 2026-09-29 2026 Q3 10-Q 2026-11-16 0001493152-26-052354
us-gaap DepositsAssets Deposits Assets USD 50,000 2024-12-31 2024 FY 10-K/A 2025-08-26 0001493152-25-012343
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares 0.08 2023-04-27 2023-12-31 2023 FY 10-K 2024-03-25 0001493152-24-011146
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares 0.08 2023-04-27 2023-12-31 2023 FY 10-K 2024-03-25 0001493152-24-011146
us-gaap IncomeTaxExaminationPenaltiesAndInterestExpense Income Tax Examination, Penalties and Interest Expense USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052354
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052354
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD -130,704 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052354
us-gaap IncreaseDecreaseInDueFromRelatedPartiesCurrent Increase (Decrease) in Due from Related Parties, Current USD -90,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052354
us-gaap IncreaseDecreaseInNotesPayableRelatedPartiesCurrent Increase (Decrease) in Notes Payable, Related Parties, Current USD 3,618 2023-04-27 2023-12-31 2024 FY 10-K/A 2025-08-26 0001493152-25-012343
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD 48,023 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052354
us-gaap InvestmentIncomeDividend Investment Income, Dividend USD 330,527 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052354
us-gaap InvestmentsFairValueDisclosure Investments, Fair Value Disclosure USD 12.28M 2026-03-31 2026 Q1 10-Q 2026-06-16 0001493152-26-028880
us-gaap Liabilities Liabilities USD 4.82M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052354
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 12.79M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052354
us-gaap LiabilitiesCurrent Liabilities, Current USD 4.13M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052354
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 887,229 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052354
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -308,979 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052354
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -577,806 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052354
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -68,552 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052354
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 330,527 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052354
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-06-16 0001493152-26-028880
us-gaap OperatingCostsAndExpenses Operating Costs and Expenses USD 399,079 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052354
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -399,079 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052354
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 1.48M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052354
us-gaap OtherReceivables Other Receivables USD 302 2024-03-31 2024 Q1 10-Q 2024-05-13 0001493152-24-018883
us-gaap OtherShortTermBorrowings Other Short-term Borrowings USD 2.33M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052354
us-gaap PaymentsForRepurchaseOfEquity Payments for Repurchase of Equity USD 65.33M 2025-01-01 2025-12-31 2026 Q3 10-Q 2026-11-16 0001493152-26-052354
us-gaap PaymentsOfFinancingCosts Payments of Financing Costs USD 2.07M 2023-04-27 2023-12-31 2024 FY 10-K/A 2025-08-26 0001493152-25-012343
us-gaap PaymentsToAcquireInvestments Payments to Acquire Investments USD 69.69M 2023-04-27 2023-12-31 2024 FY 10-K/A 2025-08-26 0001493152-25-012343
us-gaap PaymentsToAcquireOtherInvestments Payments to Acquire Other Investments USD 308,979 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052354
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 48,023 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052354
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 25,000 2023-04-27 2023-12-31 2024 FY 10-K/A 2025-08-26 0001493152-25-012343
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 3.32M 2023-04-27 2023-12-31 2024 FY 10-K/A 2025-08-26 0001493152-25-012343
us-gaap ProceedsFromIssuanceOfUnsecuredDebt Proceeds from Issuance of Unsecured Debt USD 150,000 2025-06-06 2025 Q2 10-Q 2025-08-13 0001493152-25-011904
us-gaap ProceedsFromOtherEquity Proceeds from Other Equity USD 69.00M 2023-04-27 2023-12-31 2024 FY 10-K/A 2025-08-26 0001493152-25-012343
us-gaap ProceedsFromOtherShortTermDebt Proceeds from Other Short-term Debt USD 308,979 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052354
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 578,250 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052354
us-gaap ProceedsFromSaleOfRestrictedInvestments Proceeds from Sale of Restricted Investments USD 31.27M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052354
us-gaap RepaymentsOfRelatedPartyDebt Repayments of Related Party Debt USD 210,151 2023-04-27 2023-12-31 2024 FY 10-K/A 2025-08-26 0001493152-25-012343
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -4.77M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052354
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 187,500 2023-09-30 2024 Q3 10-Q 2024-11-13 0001493152-24-045119
us-gaap SharePrice Share Price USD/shares 10.1 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052354
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 10 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052354
us-gaap SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Number of Shares shares 1.04M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052354
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD -4.77M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052354
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 25,000 2023-04-27 2023-12-31 2023 FY 10-K 2024-03-25 0001493152-24-011146
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 69.00M 2023-04-27 2023-12-31 2024 FY 10-K/A 2025-08-26 0001493152-25-012343
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 3.32M 2023-04-27 2023-12-31 2024 FY 10-K/A 2025-08-26 0001493152-25-012343
us-gaap StockRedeemedOrCalledDuringPeriodShares Stock Redeemed or Called During Period, Shares shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052354
us-gaap StockRedeemedOrCalledDuringPeriodValue Stock Redeemed or Called During Period, Value USD 31.27M 2025-02-05 2026 Q3 10-Q 2026-11-16 0001493152-26-052354
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 12.74M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052354
us-gaap TemporaryEquityParOrStatedValuePerShare Temporary Equity, Par or Stated Value Per Share USD/shares 0 2023-12-31 2023 FY 10-K 2024-03-25 0001493152-24-011146
us-gaap TemporaryEquityRedemptionPricePerShare Temporary Equity, Redemption Price Per Share USD/shares 12.25 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052354
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 500.00M 2023-12-31 2023 FY 10-K 2024-03-25 0001493152-24-011146
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 1.04M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052354
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 1.04M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052354
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052354
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 2.23M 2023-04-27 2023-12-31 2023 FY 10-K 2024-03-25 0001493152-24-011146
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 2.23M 2023-04-27 2023-12-31 2023 FY 10-K 2024-03-25 0001493152-24-011146

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →